| Role |
Name |
Disclosure |
Details |
| Author | Anna M Barrett, MD, Associate Professor of Physical Medicine and Rehabilitation and Neurology and Neurosciences, University of Medicine and Dentistry of New Jersey, New Jersey Medical School; Director, Stroke Rehabilitation Research Program, Kessler Medical Rehabilitation Research and Education Center | Nothing to disclose | Details | | Coauthor | Sylvia T John, MBBS, Consulting Staff, Brain Injury Unit, Rehabilitation Medicine Associates, Southside Hospital | Nothing to disclose | Details | | Medical Editor | Daniel H Jacobs, MD, Associate Professor of Neurology, University of Central Florida College of Medicine | Teva Pharmaceutical Biogen Idex Serono EMD Pfizer Berlex | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Nestor Galvez-Jimenez, MD, MSc, MHA, Chairman, Department of Neurology, Program Director, Movement Disorders, Department of Neurology, Division of Medicine, Cleveland Clinic Florida | Nothing to disclose | Details | | CME Editor | Selim R Benbadis, MD, Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, University of South Florida School of Medicine, Tampa General Hospital | Nothing to disclose | Details | | Chief Editor | Howard A Crystal, MD, Professor, Departments of Neurology and Pathology, State University of New York Downstate; Consulting Staff, Department of Neurology, University Hospital and Kings County Hospital Center | Pfizer Myriad | Details |
|